More severe neurologic deficits in SJL/J male than female mice following Theiler's virus-induced CNS demyelination

Experimental Neurology

Volumn 180, Issue 1, 2003, Pages 14-24

  Alley, Jeremy ^a   Khasabov, Sergey ^a   Simone, Don ^a   Beitz, Alvin ^a   Rodriguez, Moses ^b   Njenga, M Kariuki ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Demyelination; Gender; Multiple sclerosis; Neurologic deficits; Theiler's virus

Indexed keywords

IMMUNOGLOBULIN G;

ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY EQUILIBRIUM; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; COORDINATION; CORRELATION ANALYSIS; DEMYELINATING DISEASE; DEMYELINATION; FEMALE; HEREDITY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MODEL; MOLECULAR BIOLOGY; MOTOR ACTIVITY; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SEX DIFFERENCE; TASK PERFORMANCE; VIRUS INFECTION; WHITE MATTER;

EID: 0037348074     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(02)00054-7     Document Type: Article

References (46)

1. Amandusson A., Hermanson O., Blomqvist A. Estrogen receptor-like immunoreactivity in the medullary and spinal dorsal horn of the female rat. Neurosci. Lett. 196:1995;25-28.
2. Bansil S., Lee H.J., Jindal S., Holtz C.R., Cook S.D. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta. Neurol. Scand. 99:1999;91-94.
3. Bebo B.F. Jr., Vandenbark A.A., Offner H. Male SJL mice do not relapse after induction of EAE with PLP 139-151. J. Neurosci. Res. 45:1996;680-689.
4. Bebo B.F. Jr., Schuster J.C., Vandenbark A.A., Offner H. Gender differences in experimental autoimmune encephalomyelitis develop during the induction of the immune response to encephalitogenic peptides. J. Neurosci. Res. 52:1998;420-426.
5. Bebo B.F. Jr., Adlard K., Schuster J.C., Unsicker L., Vandenbark A.A., Offner H. Gender differences in protection from EAE induced by oral tolerance with a peptide analogue of MBP-Ac1-11. J. Neurosci. Res. 55:1999;432-440.
6. Beeson P.B. Age and sex associations of 40 autoimmune diseases. Am. J. Med. 96:1994;457-462.
7. Borrow P., Tonks P., Welsh C.R., Nash A.A. The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 73:1992;1861-1865.
8. Bronnum-Hansen H., Koch-Henriksen N., Hyllested K. Survival of patients with multiple sclerosis in Denmark a nationwide, long-term epidemiologic survey . Neurology. 44:1994;1901-1907.
9. Celius E.G., Harbo H.F., Egeland T., Vartdal F., Vandvik B., Spurkiand A. Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis. J. Neurol. Sci. 178:2000;132-135.
10. Cerinic M.M., Konttinen Y., Generini S., Cutolo M. Neuropeptides and steroid hormones in arthritis. Curr. Opin. Rheumatol. 10:1998;220-235.
11. Cohen J.H.M., Danel L., Cordier G., Saez S., Revillard J.P. Sex steroid receptors in peripheral T cells absence of androgen receptor and restriction of estrogen receptor to OKT8-positive cells . J. Immunol. 131:1983;2767-2771.
12. Cottrell D.A., Kremenchutzky M., Rice G.P.A., Koopman W.J., Hader W., Bakerville J., Ebers G.C. The natural history of multiple sclerosis a geographically based study 5. The clinical features and natural history of primary progressive multiple sclerosis . Brain. 122:1999;625-639.
13. Dal Canto M.C., Lipton H.L. Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J. Neurol. Sci. 42:1979;391-405.
14. Drew P.D., Chavis J.A. Female sex steroids effects upon microglial cell activation . J. Neuroimmunol. 111:2000;77-85.
15. Duquette P., Pleines J., Girard M., Charest L., Senecal-Quevillon M., Masse C. The increased susceptibility of women to multiple sclerosis. Can. J. Neurol. Sci. 19:1992;466-471.
16. Ford H.L., Gerry E., Airey C.M., Vail A., Johnson M.H., Williams D.R. The prevalence of multiple sclerosis in the Leeds Health Authority. J. Neurol. Neurosurg. Psychiatry. 64:1998;605-610.
17. Gaillard R.C., Spinedi E. Sex- and stress-steroids interactions and the immune system evidence for a neuroendocrine-immunological sexual dimorphism . Domest. Anim. Endocrinol. 15:1998;345-352.
18. Gilmore W., Wener L.P., Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J. Immunol. 158:1997;446-451.
19. Hill K.E., Pigmans M., Fujinami R.S., Rose J.W. Gender variations in early Theiler's virus induced demyelinating disease differential susceptibility and effects of IL-4, IL-10 and combined IL-4 with IL-10 . J. Neuroimmunol. 85:1998;44-51.
20. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84:1997;223-443.
21. Lipton H.L. Theiler's virus infection in mice an unusual biphasic disease process leading to demyelination . Infect. Immun. 11:1975;1147-1155.
22. Lumbroso S., Sandillon F., Georget V., Lobaccaro J.M., Brinkmann A.O., Privat A., Sultan C. Immunohistochemical localization and immunoblotting of androgen receptor in spinal neurons of male and female rats. Eur. J. Endocrinol. 134:1996;626-632.
23. McDonnell G.V., Hawkins S.A. Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J. Neurol. Neurosurg. Psychiatry. 64:1998;451-454.
24. McGavern D., Murray P.D., Rivera-Quinones C., Schmelzer J.D., Low P.A., Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 123:2000;519-531.
25. McGavern D., Murray P.D., Rodriguez M. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury. J. Neurosci. 58:1999;492-504.
26. McGavern D., Zoecklein L., Drescher K.M., Rodriguez M. Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp. Neurol. 158:1999;171-181.
27. Miller D.J., Rivera-Quinones C., Njenga M.K., Leibowitz J., Rodriguez M. Spontaneous central nervous system remyelination in β2-microglobulin deficient mice following virus-induced demyelination. J. Neurosci. 15:1995;8345-8352.
28. Moreau T., Manceau E., Lucas B., Lemesle M., Urbinelli R., Giroud M. Incidence of multiple sclerosis in Dijon, France a population-based ascertainment . Neurol. Res. 22:2000;156-159.
29. Nicoletti A., Lo Bartolo M.L., Lo Fermo S., Cocuzza V., Panetta M.R., Marletta C., Ciancio M.R., Cataldi M.L., Patti F., Reggio A. Prevalence and incidence of multiple sclerosis in Catania, Sicily. Neurology. 56:2000;62-66.
30. Njenga M.K., Asakura K., Hunter S.F., Wettstein P., Pease L.P., Rodriguez M. The immune system preferentially clears Theiler's virus from the gray matter of the central nervous system. J. Virol. 71:1997;8592-8601.
31. Pierce M., Rodriguez M. Erichrome stain for myelin on osmicated tissues embedded in glycol methacrylate plastic. J. Histotechnol. 12:1989;35-36.
32. Pozzilli C., Falaschi P., Mainero C., Martocchia A., D'Urso R., Proetti A., Frontoni A., Bastianello S., Filippi M. MRI in multiple sclerosis during the menstrual cycle relationship with sex . Neurology. 53:1999;622-624.
33. Rodriguez M., Leibowitz J.L., Lampert P.W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:1983;426-432.
34. Rodriguez M., Oleszak E., Leibowitz J. Theiler's murine encephalomyelitis A model of demyelination and persistence of virus . Crit. Rev. Immunol. 7:1987;325-366.
35. Roos R.P., Firestone S., Wollmann R., Variakojis D., Arnason B.G.W. The effects of short term and chronic immunosuppression on Theiler's virus demyelination. J. Neuroimmunol. 2:1982;223-234.
36. Roos R.P., Wollmann R. DA strain of Theiler's murine encephalomyelitis virus induces demyelination in nude mice. Ann. Neurol. 15:1984;494-499.
37. Rosenthal A., Fujinami R.S., Lampert P.W. Mechanism of Theiler's virus-induced demyelination in nude mice. Lab. Invest. 54:1986;515-522.
38. Smith R., Studd J.M. A pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and menstrual cycle. J.R. Soc. Med. 85:1992;612-613.
39. Stimson W.H. Oestrogen and human T lymphocytes presence of specific receptors in the T suppressor/cytotoxic subset . Scand. J. Immunol. 28:1998;345-350.
40. Totaro R., Marini C., Cialfi A., Giunta M., Carolei A. Prevalence of multiple sclerosis in the L'Aquila district, central Italy. J. Neurol. Neurosurg. Psychiatry. 68:2000;349-352.
41. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:1998;278-285.
42. Trooster W.J., Teelken A.W., Gerrits P.O., Lijnema T.H., Loof J.G., Minderhoud J.M., Nieuwenheuis P. The effect of gonadectomy on the clinical course of chronic experimental allergic encephalomyelitis. Clin. Neurol. Neurosurg. 98:1996;222-226.
43. Vein A.M., Voznesenskaia T.G., Khromova L.G. The course of disseminated sclerosis in men and women. Zh. Nevropatol. Psikhiatr. Im. S. Korsakova. 95:1995;43-44.
44. Verthelyi D. Sex hormones as immunomodulators in health and disease. Int. Immunopharmacol. 1:2001;983-993.
45. Wynn D.R., Rodriguez M., O'Fallon W.M., Kurland L.T. A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota. Neurology. 40:1990;780-786.
46. Zurbriggen A., Yamada M., Thomas C., Fujinami R.S. Restricted virus replication in the spinal cord of nude mice infected with Theiler's virus variants. J. Virol. 65:1991;1023-1030.